Design, Synthesis, and Antitumor Activity of Β-Carboline- Benzimidazole Hybrids

Siyu Zhu,Xinyu Huo,Qin Ma,Wei Chen,Jie Zhang,Liang Guo
DOI: https://doi.org/10.6023/cjoc202110025
2022-01-01
Chinese Journal of Organic Chemistry
Abstract:In a continuing effort to develop novel beta-carboline derivatives endowed with better pharmacological profiles, a series of 1,9-disubstituted beta-carboline-benzimidazole hybrids with various substituents were designed and synthesized from L-tryptophan and aldehydes. The target compounds were subjected to antitumor screening against five different cancer cell lines, namely, A549 (lung carcinoma), BGC-823 (gastric carcinoma), CT-26 (murine colon carcinoma), Bel-7402 (liver carcinoma), and MCF-7 (breast carcinoma), using standard methyl thiazolyl tetrazolium (MTT)assay. The structure-activity relationships (SARs) of the conjugates with different substituents at positions 1 and 9 in beta-carbolines were also analyzed. The obtained results showed that most conjugates exhibited good cytotoxic activity against more than one cancer cell line. In particular, compound 5s with a benzyl group at position-9 and a trifluoromethyl substituent on the benzimidazole ring had the highest activity against MCF-7 cells (IC50 value of 4.9 +/- 0.3 mu mol/L). Compounds 5c and 5q displayed significant cytotoxicity against three tumor cell lines, with IC50 values lower than 10 mu mol/L. Moreover, these two compounds could moderately reduce the number of migrated cells at concentrations of 2.5 similar to 10 mu g.mL(-1).
What problem does this paper attempt to address?